09.22.26 -- AI Fills The Decision-Making Gaps In Process Analytical Technology

Don't let idle assets drain your resources. Uncover the often-overlooked expenses of equipment storage, from rental fees to lost opportunity costs, and learn how to reclaim value.

Discover how understanding hazardous area classifications and compliance requirements can help manufacturers reduce ignition risks, select appropriate equipment, and operate more safely.

Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.

In this study, two different immune cell preparations were evaluated for their compatibility to establish a USP and EP compliant method for rapid sterility testing.

Explore end-to-end strategies for therapeutic peptide characterization, including purity, structure, stability, and more, alongside expert services designed to strengthen workflow consistency.

As peptide therapeutics grow more complex, impurity profiling demands greater chromatographic confidence. See how robust reproducibility can support reliable GLP-1 receptor agonist analysis.

AI is reshaping quality in life sciences, but many teams struggle to balance innovation with audit readiness. Learn how industry leaders are managing risk and building confidence with AI.

Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.

Review how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.

Rising Annex 1 demands are pushing facilities to rethink contamination control. Delve into how RABS retrofits offer a practical path to compliance, combining effective containment and implementation.

Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.

Deploying AI in pharmacovigilance requires risk-based oversight, human accountability, transparent governance, and representative performance testing.

Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.

Take a look at how connected drug delivery solutions help accelerate study execution, improve data quality, support decentralized trials, and boost patient engagement with ready-to-use platforms.

Gain expert insights into how to develop a spray dried powder formulation and scale it from early feasibility studies to commercial manufacturing.

Pharmaceutical labeling demands precision. Examine key considerations for ensuring accuracy and efficiency in your process, from robust control systems to diverse printing options.

Comparing isolator decontamination cycle times requires evaluating key variables like aeration endpoints and load patterns to build accurate capacity models and avoid costly delays.